Skip to main content

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis

SellVALUE-TRAP 3/5Moderate Confidence

Healthcare · Medical Care Facilities

Sell if holding. Engine safety override at $24.00: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.3/10. Specifically: High short interest: 37%; Below-average business quality; Negative price momentum.

Acadia Healthcare operates 277 behavioral healthcare facilities with over 12,500 beds in 40 states and Puerto Rico, providing inpatient psychiatric, specialty substance use, and outpatient services. Revenue was $3,312.8 million in 2025; 57.7% from Medicaid, 24.6% from commercial... Read more

$24.00+16.6% A.UpsideScore 5.3/10#15 of 27 Medical Care Facilities
Stop $22.34Target $28.00(resistance)A.R:R -1.1:1
Analyst target$24.04+0.1%14 analysts
$28.00our TP
$24.00price
$24.04mean
$13
$31

Sell if holding. Engine safety override at $24.00: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.3/10. Specifically: High short interest: 37%; Below-average business quality; Negative price momentum. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.3/10, moderate confidence.

Passes 3/6 gates (clean insider activity, earnings proximity no date, semi cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.

Thesis

Rewards
No bull case signals
Risks
Concentration risk — Regulatory: Medicaid (57.7%)
Target reached (-12.9% upside)
Quality below floor (3.2 < 4.0)

Key Metrics

P/E (TTM)
P/E (Fwd)16.8
Mkt Cap$2.6B
EV/EBITDA9.2
Profit Mgn-33.3%
ROE-41.0%
Rev Growth6.1%
Beta0.71
DividendNone
Rating analysts20

Quality Signals

Piotroski F8/9

Options Flow

P/C0.38bullish
IV77%elevated
Max Pain$15-37.5% vs spot

Concentration Risks(10-K Item 1A)

  • HIGHregulatoryMedicaid58%
    10-K Item 1: 'For the year ended December 31, 2025, we received 57.7% of our revenue from Medicaid, 24.6% from commercial payors, 14.3% from Medicare and 3.4% from other payors'

Material Events(8-K, last 90d)

  • 2026-04-23Item 5.02MEDIUM
    CFO Todd Young to resign effective April 30, 2026. David M. Duckworth appointed as Interim CFO effective May 1, 2026. Duckworth previously served as Acadia CFO from 2012–2023. No reason cited for Young departure.
    SEC filing →
  • 2026-03-12Item 5.02LOW
    Wade Miquelon retiring from Board at 2026 annual meeting (notified March 9). Daniel Cancelmi appointed as Class III director March 12, 2026, serving on Audit Committee. Board expanded from 10 to 11 directors.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

3 floor-breakers

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank
0.0
Growth Rank
3.5
Value Rank
5.9

Unprofitable operations — net margin -33.3%. Quality floor flags this regardless of sector context.static

Roe
0.0
Net Margin
0.0
Fcf Quality
0.0
Operating Margin
2.3
Roa
2.8
Gross Margin
4.3
Moat
5.0
Current Ratio
5.7
Piotroski F
8.9
Cash-burning: FCF -11% of revenueNo competitive moatStrong Piotroski F-Score: 8/9

Momentum below the gate floor. Component breakdown shows what dragged the score down.static

Macd
0.0
Obv
1.0
Vol Acceleration
2.9
Ma Position
4.0
Rsi
5.5
Volume
10.0
Volume distribution (falling OBV)Above 200-day MAVolume surge (2.1x avg) on selloff
GatesMomentum 3.9<4.5A.R:R -1.1=NEGATIVEExecutive change: officer departure/appointmentInsider activity: OKEARNINGS PROXIMITY NO DATESEMI CYCLE PEAK CLEARSuitability: Aggressive
RSI
40 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $21.60Resistance $28.57

Price Targets

$22
$28
A.Upside+16.7%
A.R:R-1.1:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-12.9% upside)
! Quality below floor (3.2 < 4.0)
! Value-trap signals (3/5): Margin compression (op margin -123.4%), Material insider selling (5 sells, 0.02% of cap), Negative free cash flow

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-04-29 (nulld)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is ACHC stock a buy right now?

Sell if holding. Engine safety override at $24.00: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.3/10. Specifically: High short interest: 37%; Below-average business quality; Negative price momentum. Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $22.34. Score 5.3/10, moderate confidence.

What is the ACHC stock price target?

Take-profit target: $28.00 (+16.6% upside). Prior stop was $22.34. Stop-loss: $22.34.

What are the risks of investing in ACHC?

Concentration risk — Regulatory: Medicaid (57.7%); Target reached (-12.9% upside); Quality below floor (3.2 < 4.0).

Is ACHC overvalued or undervalued?

Acadia Healthcare Company, Inc. trades at a P/E of N/A (forward 16.8). TrendMatrix value score: 7.3/10. Verdict: Sell.

What do analysts say about ACHC?

20 analysts cover ACHC with a consensus score of 3.7/5. Average price target: $24.

What does Acadia Healthcare Company, Inc. do?Acadia Healthcare operates 277 behavioral healthcare facilities with over 12,500 beds in 40 states and Puerto Rico,...

Acadia Healthcare operates 277 behavioral healthcare facilities with over 12,500 beds in 40 states and Puerto Rico, providing inpatient psychiatric, specialty substance use, and outpatient services. Revenue was $3,312.8 million in 2025; 57.7% from Medicaid, 24.6% from commercial payors, and 14.3% from Medicare.

Related stocks: AVAH (Aveanna Healthcare Holdings Inc) · ADUS (Addus HomeCare Corporation) · ASTH (Astrana Health Inc.) · CON (Concentra Group Holdings Parent) · THC (Tenet Healthcare Corporation)